Original Research
Published on 29 Nov 2022
Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.985618
- 5,711 views
- 11 citations




